ClassID:

94341

C07D223/24 - CPC Classification

Classification description:

Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems; Dibenzazepines; Hydrogenated dibenzazepines; Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines with hydrocarbon radicals, substituted by nitrogen atoms, attached to the ring nitrogen atom

Sub-classes:
Recent Application in this class:
#1
20260071120
2026-03-12

NOVEL COMPOUND, ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME, AND ELECTRONIC APPARATUS

#2
20230373900
2023-11-23

CYCLOPROPENIUM COMPOUNDS, PROCESS FOR THEIR PREPARATION AND USE

#3
20220289726
2022-09-15

NOVEL COMPOUND, ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME, AND ELECTRONIC APPARATUS

#4
20220289704
2022-09-15

ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE USING SAME

#5
20190135809
2019-05-09

Pro-Neurogenic Compounds

#6
20170305906
2017-10-26

Pro-Neurogenic Compounds

#7
20160222026
2016-08-04

Dibenzo[B,F][1,4]oxazepin-11-yl-N-Hydroxybenzamides as HDAC Inhibitors

#8
20160000933
2016-01-07

CONJUGATED BIOLOGICAL MOLECULES AND THEIR PREPARATION

#9
20150148301
2015-05-28

Inhibitors of the activity of complex (III) of the mitochondrial electron transport chain and use thereof

#10
20150018543
2015-01-15

ANTI-INFECTIVE COMPOUNDS

#11
20140057900
2014-02-27

Pro-neurogenic compounds

#12
20110196147
2011-08-11

INHIBITORS OF HISTONE DEACETYLASE

#13
20110178077
2011-07-21

Anti-infective compounds

#14
20100051106
2010-03-04

Novel organic electroluminescent compounds and organic electroluminescent device using the same

#15
20080207590
2008-08-28

Dibenzo[b,f][1,4]oxazepin-11-yl-N-hydroxybenzamides as HDAC inhibitors

#16
20070249618
2007-10-25

Novel Piperidine Derivatives as Histamine H3 Receptor Ligands for Treatment of Depression

#17
20070176541
2007-08-02

Organic light emitting compound and organic light emitting device comprising the same

#18
20060142566
2006-06-29

Enantioselective process for the preparation of both enantiomers of 10,11-dihydro-10-hydroxy-5h-dibenz[b,f]azepine-5-carboxamide and new crystal forms thereof